Dr Lal (India) Quote Today

Equity ratings for Dr Lal Pathlabs are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 14th of August 2019 and ending today, the 3rd of August 2021. Click here to learn more.
Dr Lal Pathlabs cannot be verified against its exchange. Apparently, Dr Lal is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Dr Lal Stock Profile

Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India. Dr Lal operates under Diagnostics Research classification in India and is traded on Bombay Stock Exchange. It employs 4190 people.. The public information regarding Dr Lal Pathlabs's current market price is not available at this time.
Dr Lal Pathlabs is not yet fully synchronised with the market data
Dr Lal Pathlabs has some characteristics of a very speculative penny stock
Dr Lal Pathlabs has high likelihood to experience some financial distress in the next 2 years
Legal NameDr Lal Pathlabs
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Dr Lal's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
Dr Lal Pathlabs (LALPATHLAB) is traded on Bombay Stock Exchange in India and employs 4,190 people. The company currently falls under 'Large-Cap' category with current market capitalization of 89.77 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Dr Lal's market, we take the total number of its shares issued and multiply it by Dr Lal's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Dr Lal Pathlabs operates under Healthcare sector and is part of Diagnostics & Research industry. The entity has 83.34 M outstanding shares. Dr Lal Pathlabs has accumulated about 6.74 B in cash with 2.19 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 81.81.
Check Dr Lal Probability Of Bankruptcy

LALPATHLAB Stock Against Markets

Picking the right benchmark for Dr Lal stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Dr Lal stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Dr Lal is critical whether you are bullish or bearish towards Dr Lal Pathlabs at a given time.
Dr Lal Pathlabs cannot be verified against its exchange. Apparently, Dr Lal is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dr Lal stock to make a market-neutral strategy. Peer analysis of Dr Lal could also be used in its relative valuation, which is a method of valuing Dr Lal by comparing valuation metrics with similar companies.
Check out Stocks Correlation. Note that the Dr Lal Pathlabs information on this page should be used as a complementary analysis to other Dr Lal's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Tools for LALPATHLAB Stock

When running Dr Lal Pathlabs price analysis, check to measure Dr Lal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Lal is operating at the current time. Most of Dr Lal's value examination focuses on studying past and present price action to predict the probability of Dr Lal's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Dr Lal's price. Additionally, you may evaluate how the addition of Dr Lal to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go